Amgen To Present at The Cowen 2nd Annual Virtual Oncology Innovation Summit

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit on May 21, 2021, at 11:20 a.m. ET. Dr. David M. Reese, the executive vice president of Research and Development, will represent the company. The conference call will be streamed live, accessible to media, investors, and the public via Amgen's website. An archived version of the webcast will be available for at least 90 days post-event. Amgen is committed to discovering and delivering innovative therapies targeting high unmet medical needs, advancing human health since 1980.

THOUSAND OAKS, Calif., May 19, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit at 11:20 a.m. ET on Friday, May 21, 2021. David M. Reese, M.D., executive vice president of Research and Development at Amgen, will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given at certain investor and medical conferences, can be accessed on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen 

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.  

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.  

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Michael Strapazon, 805-313-5553 (media) 
Arvind Sood, 805-447-1060 (investors) 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-cowen-2nd-annual-virtual-oncology-innovation-summit-301295491.html

SOURCE Amgen

FAQ

When will Amgen present at the Cowen Oncology Innovation Summit?

Amgen will present at the Cowen 2nd Annual Virtual Oncology Innovation Summit on May 21, 2021, at 11:20 a.m. ET.

Who will represent Amgen at the Cowen Oncology Summit?

Dr. David M. Reese, the executive vice president of Research and Development, will represent Amgen at the summit.

How can I access the Amgen conference call?

The Amgen conference call can be accessed live via their website, and it will be available for replay for at least 90 days after the event.

What is Amgen's focus in drug development?

Amgen focuses on unlocking the potential of biology to create innovative human therapeutics for serious illnesses.

What is the significance of the Cowen Oncology Innovation Summit for Amgen?

The Cowen Oncology Innovation Summit allows Amgen to share insights into its research and developments in oncology with the broader medical and investment communities.